GSK vs. WBA
Compare and contrast key facts about GlaxoSmithKline plc (GSK) and Walgreens Boots Alliance, Inc. (WBA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GSK or WBA.
Correlation
The correlation between GSK and WBA is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GSK vs. WBA - Performance Comparison
Loading data...
Key characteristics
GSK:
21.36%
WBA:
7.09%
GSK:
-5.74%
WBA:
-0.09%
GSK:
-5.74%
WBA:
0.00%
Fundamentals
GSK:
$74.41B
WBA:
$9.70B
GSK:
$2.02
WBA:
-$6.69
GSK:
0.36
WBA:
3.55
GSK:
2.45
WBA:
0.06
GSK:
3.95
WBA:
1.36
GSK:
$31.53B
WBA:
$151.95B
GSK:
$22.56B
WBA:
$26.43B
GSK:
$8.24B
WBA:
-$3.02B
Returns By Period
GSK
N/A
N/A
N/A
N/A
N/A
N/A
WBA
N/A
N/A
N/A
N/A
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GSK vs. WBA — Risk-Adjusted Performance Rank
GSK
WBA
GSK vs. WBA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for GlaxoSmithKline plc (GSK) and Walgreens Boots Alliance, Inc. (WBA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
GSK vs. WBA - Dividend Comparison
GSK's dividend yield for the trailing twelve months is around 4.24%, less than WBA's 6.68% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK GlaxoSmithKline plc | 4.24% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
WBA Walgreens Boots Alliance, Inc. | 6.68% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
GSK vs. WBA - Drawdown Comparison
The maximum GSK drawdown since its inception was -5.74%, which is greater than WBA's maximum drawdown of -0.09%. Use the drawdown chart below to compare losses from any high point for GSK and WBA. For additional features, visit the drawdowns tool.
Loading data...
Volatility
GSK vs. WBA - Volatility Comparison
Loading data...
Financials
GSK vs. WBA - Financials Comparison
This section allows you to compare key financial metrics between GlaxoSmithKline plc and Walgreens Boots Alliance, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GSK vs. WBA - Profitability Comparison
GSK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, GlaxoSmithKline plc reported a gross profit of 5.58B and revenue of 7.52B. Therefore, the gross margin over that period was 74.2%.
WBA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Walgreens Boots Alliance, Inc. reported a gross profit of 6.93B and revenue of 38.59B. Therefore, the gross margin over that period was 18.0%.
GSK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, GlaxoSmithKline plc reported an operating income of 2.22B and revenue of 7.52B, resulting in an operating margin of 29.5%.
WBA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Walgreens Boots Alliance, Inc. reported an operating income of -1.96B and revenue of 38.59B, resulting in an operating margin of -5.1%.
GSK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, GlaxoSmithKline plc reported a net income of 1.62B and revenue of 7.52B, resulting in a net margin of 21.6%.
WBA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Walgreens Boots Alliance, Inc. reported a net income of -2.85B and revenue of 38.59B, resulting in a net margin of -7.4%.